GlassScriptPhysician profile
Shravan Gupta
NPI 1679006738
$4,724.56
in general payments reported to CMS, 2019-2025
12 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $614 · 2022: $1,233 · 2023: $1,491 · 2024: $264 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,876.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $1,242.54 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic, INC. | $883.68 | 2022-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Boston Scientific Corporation | $691.90 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $628.96 | 2023-2024 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $596.00 | 2022-2023 | Intracept |
| Abbvie INC. | $241.17 | 2022-2025 | |
| Spinal Simplicity, LLC | $236.75 | 2023 | Ha Minuteman G3-R |
| Allergan, INC. | $108.69 | 2022 | |
| Nevro Corp. | $26.66 | 2024 | Senza |
| Spr Therapeutics, INC | $23.83 | 2022 | |
| Merz Pharmaceuticals, LLC | $22.77 | 2024 | Xeomin |
| Curonix LLC | $21.61 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shravan Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.